He, Benyi
Deng, Min
Guan, Renguo
Mei, Jie
Zou, Hao
Tang, Yuhao
Yang, Zhenyun
Zheng, Zehao
Lin, Wenping
Li, Shaohua
Guo, Rongping
Zhao, Rongce
Wei, Wei
Funding for this research was provided by:
Shenzhen Science and Technology Innovation Committee (JCYJ20250604143712016)
National Natural Science Foundation of China (No. 82172579, No.82303879, No.82303875, No.82203111)
Guangdong Provincial Natural Science Foundation (2024A1515012581)
Science and Technology Planning Project of Guangzhou (No.2023A04J1777, No. 2023A04J1781, No.202206080016)
Guangdong Medical Science and Technology Research Fund Project (A2022366)
National Major Science and Technology Projects of China (2024ZD0520402)
Clinical Trials Project (5010 Project) of Sun Yat-sen University (No.5010-2017009, No. 5010-2023001)
Article History
Received: 4 August 2025
Accepted: 24 January 2026
First Online: 9 February 2026
Declarations
:
: The study protocol and methods were carried out in accordance with relevant guidelines and approved by the Clinical Research Ethics Committee of SYSUCC. HCC samples were collected by surgical resection. Informed consent was obtained from the patients and their families for the surgery and collection of samples. The study protocol received approval from the Sun Yat-sen University Cancer Center’s IRB and IEC (Approval No. B2018-126-01), adhering to the Declaration of Helsinki.
: No individual patient data are presented in this paper, and consent for publication was not required.
: The authors declare no competing interests.